PRICE T ROWE ASSOCIATES INC /MD/ - LIANBIO ownership

LIANBIO's ticker is and the CUSIP is 53000N108. A total of 39 filers reported holding LIANBIO in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of LIANBIO
ValueSharesWeighting
Q3 2023$3,873
-37.3%
2,598,766
-4.1%
0.00%0.0%
Q2 2023$6,180
+24.9%
2,710,214
+6.8%
0.00%0.0%
Q1 2023$4,949
+12.5%
2,537,609
-5.4%
0.00%0.0%
Q4 2022$4,398
-99.9%
2,681,497
-5.0%
0.00%0.0%
Q3 2022$5,618,000
+22.3%
2,822,857
+32.7%
0.00%0.0%
Q2 2022$4,594,000
-43.2%
2,126,878
-5.2%
0.00%0.0%
Q1 2022$8,090,000
-39.8%
2,242,3890.0%0.00%0.0%
Q4 2021$13,432,0002,242,3890.00%
Other shareholders
LIANBIO shareholders Q3 2023
NameSharesValueWeighting ↓
Perceptive Advisors 112,639,920$693,862,0005.35%
Vida Ventures Advisors, LLC 2,282,084$14,058,0005.26%
VR Adviser, LLC 5,378,341$33,131,0004.53%
SCHF (GPE), LLC 937,500$5,775,0001.04%
RA Capital Management 7,655,015$47,155,0000.83%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 3,314,173$20,415,0000.61%
Logos Global Management LP 412,837$2,543,0000.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,782,747$10,982,0000.23%
SPHERA FUNDS MANAGEMENT LTD. 275,007$1,662,0000.18%
Affinity Asset Advisors, LLC 72,406$446,0000.16%
View complete list of LIANBIO shareholders